| Dr Robert G Ferrigni, MD | |
|
5779 E Mayo Blvd, Phoenix, AZ 85054-4502 | |
| (480) 301-8000 | |
| Not Available |
| Full Name | Dr Robert G Ferrigni |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 45 Years |
| Location | 5779 E Mayo Blvd, Phoenix, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134104748 | NPI | - | NPPES |
| 86080015085259C288 | Other | AZ | TRIWEST |
| 336330 | Medicaid | AZ | |
| 340006371 | Other | AZ | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 19385 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yuma Regional Medical Center | Yuma, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Yuma Regional Medical Center | 2062314826 | 288 |
News Archive
The vast differences between humans and chimpanzees are due more to changes in gene regulation than differences in individual genes themselves
My lab, broadly speaking, is interested in trying to understand interactions between cells and materials. Those could be materials that are present within living tissue or materials that we use for engineering purposes to try to do something of technological or therapeutic interest.
Mailed reminders to patients appear to promote colon cancer screening, according to a report in the February 23 issue of Archives of Internal Medicine.
AstraZeneca today announced high-level results from KODIAC-08, an open-label, randomised, 52-week, long-term safety trial of naloxegol versus usual care (UC) in patients with non-cancer related pain and opioid-induced constipation (OIC). UC was defined as the investigator's choice of an existing laxative treatment regimen for OIC.
Johns Hopkins researchers report the discovery of a molecular switch that regulates the behavior of a protein that, when altered, is already known to increase human susceptibility to schizophrenia and mood disorders.
› Verified 9 days ago
| Entity Name | Yuma Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194706655 PECOS PAC ID: 2062314826 Enrollment ID: O20040122000526 |
News Archive
The vast differences between humans and chimpanzees are due more to changes in gene regulation than differences in individual genes themselves
My lab, broadly speaking, is interested in trying to understand interactions between cells and materials. Those could be materials that are present within living tissue or materials that we use for engineering purposes to try to do something of technological or therapeutic interest.
Mailed reminders to patients appear to promote colon cancer screening, according to a report in the February 23 issue of Archives of Internal Medicine.
AstraZeneca today announced high-level results from KODIAC-08, an open-label, randomised, 52-week, long-term safety trial of naloxegol versus usual care (UC) in patients with non-cancer related pain and opioid-induced constipation (OIC). UC was defined as the investigator's choice of an existing laxative treatment regimen for OIC.
Johns Hopkins researchers report the discovery of a molecular switch that regulates the behavior of a protein that, when altered, is already known to increase human susceptibility to schizophrenia and mood disorders.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert G Ferrigni, MD 5779 E Mayo Blvd, Phoenix, AZ 85054-4502 Ph: (480) 301-8000 | Dr Robert G Ferrigni, MD 5779 E Mayo Blvd, Phoenix, AZ 85054-4502 Ph: (480) 301-8000 |
News Archive
The vast differences between humans and chimpanzees are due more to changes in gene regulation than differences in individual genes themselves
My lab, broadly speaking, is interested in trying to understand interactions between cells and materials. Those could be materials that are present within living tissue or materials that we use for engineering purposes to try to do something of technological or therapeutic interest.
Mailed reminders to patients appear to promote colon cancer screening, according to a report in the February 23 issue of Archives of Internal Medicine.
AstraZeneca today announced high-level results from KODIAC-08, an open-label, randomised, 52-week, long-term safety trial of naloxegol versus usual care (UC) in patients with non-cancer related pain and opioid-induced constipation (OIC). UC was defined as the investigator's choice of an existing laxative treatment regimen for OIC.
Johns Hopkins researchers report the discovery of a molecular switch that regulates the behavior of a protein that, when altered, is already known to increase human susceptibility to schizophrenia and mood disorders.
› Verified 9 days ago
Dr. Donald E Novicki, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 5779 E Mayo Blvd, Phoenix, AZ 85054 Phone: 480-301-8000 | |
Dr. Scott K Swanson, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5779 E Mayo Blvd, Phoenix, AZ 85054 Phone: 480-301-8000 | |
Robert B. Bailey Jr., M.D. Urology Medicare: Medicare Enrolled Practice Location: 1920 E Cambridge Ave, Suite 302, Phoenix, AZ 85006 Phone: 602-279-1697 Fax: 602-264-0461 | |
Dr. Ryan James Powers, DO Urology Medicare: Accepting Medicare Assignments Practice Location: 33300 N 32nd Ave Ste 201, Phoenix, AZ 85085 Phone: 602-264-0608 | |
Dr. Christopher James Joseph Martin, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5133 N Central Ave Ste 206, Phoenix, AZ 85012 Phone: 602-264-0608 Fax: 602-234-0417 | |
Dr. Mitchell R Humphreys, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5779 E Mayo Blvd, Phoenix, AZ 85054 Phone: 480-301-8000 |